More than 10% of elite athletes could be cheating, says Wada director general David Howman but the number of children doping to reach the elite is the World Anti-Doping Agency's "biggest concern".
Howman said sport's increasing profitability had led to young athletes becoming more "vulnerable".
Drug testing is limited in non-elite events, and Howman admits teenagers are "under the radar" of doping agencies.
He also said doping could become a criminal offence in five years.
"We have some guestimates based on some research undertaken over the last years," Howman told BBC's Hardtalk.
"It's far more than we would wish it to be - over 10%. That is of concern because those being caught by the system is far lower than that. Not in all sports, in some sports," he said.
"The area of most concern for us is the level of young athletes who have not broken through into the elite who are trying to get that breakthrough and are susceptible to taking drugs because that's a shortcut," he added.
"Not only are they susceptible to taking drugs, they are being encouraged to do so by any one of a number of people that surround them - coaches, trainers, even parents - because it's way to make a lot of money."
Nigerian weightlifter Chika Amalaha, 16, was stripped of her gold medal after failing a drugs test at last year's Commonwealth Games.


Doubts about cycling

Former Wada president Dick Pound has previously said that four out of five cheats are not being caught.
And Howman said he wondered if there were still riders doping on this year's Tour de France after former winner Lance Armstrong was stripped of seven titles following his admission he took performance-enhancing drugs.
Leader Chris Froome has been questioned about his performance during this year's race but the Team Sky rider has denied doping.
Howman said that the numbers of riders doping had fallen "majorly" since Armstrong won Tours from 1999 to 2005, adding: "I have great respect for the way in which the UCI [world cycling's governing body] are now running their anti-doping programme."


Some of the Middle East's most highly prized archaeological treasures are under threat from the extremist militants of Islamic State (IS).
So archaeologists are desperately trying to record as much of these sites as they can.
And, in contrast to Indiana Jones and its low-tech bullwhip, they're using the latest technology to do it.
But it may already be too late for the ancient city of Palmyra in Syria. This once-rich oasis straddling age-old caravan routes, featuring colonnaded porticos and the sleek sandstone Tower of Elahbel, fell to IS on 21 May 2015.
The city is now strewn with landmines.
And according to reports, the militants promptly destroyed the 1,900-year-old Lion of Al-lat statue.


Digital ghosts

No wonder archaeologist Roger Michel is in a hurry to preserve - if only in digital form - the relics lying in the militants' onward path.
Mr Michel's team from the Institute of Digital Archaeology - a joint venture between Harvard University and the Classics Conclave - is hoping to flood the area with 3D cameras and enlist local partners to photograph as many items of historical interest as they can.
"If we can get 5,000-to-10,000 [3D cameras] in the field in the next three or six months," he says, "then, if we can't protect these things at the ground, we can at least preserve a highly detailed record of what's there."
He is relying on a patchwork of local museums, non-governmental organisations and volunteers to carry out the digital archiving.

But taking and uploading complex photos in hot, desert conditions where internet access is patchy is challenging.
The cameras need to be robust, have a long battery life and be capable of uploading large files.
"We're working a lot on the battery, since there will be limited access to electricity," Mr Michel says.
They have partnered with New York University's Institute for the Study of the Ancient World to store the 3D images, and with Massachusetts Institute of Technology Three Dimensional Printing Laboratory to print them.

View from the air

The threat from IS has added a new urgency to archaeologists' attempts to record mankind's cultural history.
The Universities of Oxford and Leicester have been using satellite imagery and aerial photography as part of a project called Endangered Archaeology in the Middle East and North Africa.
The £1.2m project will create an open-access database, registering information about each site and its condition, all in easily accessible Geographic Information System [GIS] format.
Remote monitoring is particularly useful in war-ravaged countries like Syria, Iraq, and Libya where on-the-ground surveys are dangerous.


Cheap drugs normally used to strengthen bone can cut deaths from breast cancer, research shows.
A charity said it was one of the most important findings in breast cancer treatment for a decade and could save 1,000 lives a year in the UK.
The data from 18,766 women, published in the Lancet, showed the drugs prevented secondary tumours growing in the bone.
The drugs are not currently available for this purpose on the NHS.
By the time a tumour is removed from the breast there is always a risk that tiny fragments have already spread.
Bone is the favourite second home of breast cancer where it can lie dormant for years.


Bone booster

Bisphosphonates are mainly used to prevent bone loss in osteoporosis.
It is thought they can effectively starve any cancerous cells that do spread to the bone to stop them growing.
Some women take them after a cancer has been detected in their bones.
But the Early Breast Cancer Trialists' Collaborative Group, co-ordinated by the University of Oxford, analysed the impact of intervening earlier.
It analysed data from 26 separate trials of women who were given the drug for up to five years after a cancer was removed from their breast.
The results showed a 28% reduction in cancers emerging in the bone, but only in post-menopausal women.
Deaths were cut by 18% over the 10 years after they were first diagnosed.
Prof Rob Coleman, who analysed the data at the University of Sheffield, told the BBC News website: "The magnitude of the benefit on mortality was bigger than we had anticipated - a risk reduction of 18% is quite sizeable."
However, the drug is not licensed for use unless a cancer has been discovered in the bone.
And as the drug is out of patent there is little financial incentive for a pharmaceutical company to change the licence.
Prof Coleman added: "The access issue is an important one. It would be a great shame if the systems we have to work with prove to be a block.
"Normally the problem is we can't afford [a new drug] but this is peanuts, it's that there isn't a mechanism for this and there needs to be."
Lady Morgan, chief executive of Breast Cancer Now, said: "We believe that this is one of the most important steps forward in breast cancer treatment since the introduction of Herceptin over 10 years ago, but this time we're talking about a few pence rather than thousands of pounds, and millions saved by the NHS.
"However, despite costing less than five pence a day per patient, this treatment runs the risk of 'sitting on the shelf', and not realising its full benefit for the 34,000 [post-menopausal] women who could be eligible to take it each year."
An NHS cancer task force led by the head of Cancer Research UK new guidelines to be produced on bisphosphonates.


It has been three years since the credit-card sized Raspberry Pi launched.
The Pi, and its community web pages, try to tempt the public and students to burrow beneath the bonnet of their computers, beyond Facebook, and try their hand at coding.
And with five million sold, it is today Britain's fastest-selling personal computer, a $35 (£25) successor to kit - or unassembled - computers like the Heathkit H8.
Eben Upton, Alan Mycroft, and four other academics at the University of Cambridge's Computer Laboratory had noted a decline in skills and numbers of students applying to read Computer Science.
Twenty years before, applicants would have been avid tinkering hobbyists; lately, they may have only done a small amount of web design.
The European Commission has predicted a shortfall of 900,000 adequately skilled programmers and other technology professionals in Europe by 2020.
So the sextet founded the Raspberry Foundation as a charity to revive Britain's garage-geek spirit.
When British astronaut Tim Peake heads to the International Space Station this November, he will bring two augmented space Raspberries, called Astro Pis.
They will run experiments devised by primary and secondary school students, says Dr Upton, Raspberry's chief executive. The older students will also code them.


Programming 2.0

Programming is changing briskly.
Coding in the cloud is one trend likely to carry on, spreading collaborators across continents.
So also is the explosion of new languages, like Facebook's Hack scripting language or Apple's Swift, alongside classical tongues like C and Java.
We're likely to learn to code younger, and differently. The has 6.2 million registered users.
The Internet of Things, driverless cars, and drones will all yield more programmable platforms - but will coding for your cappuccino maker drastically change programming?
And what will the coding workplace be like, when today's Raspberry rugrats have grown into tomorrow's programming prodigies?
One interesting facet of the last 15 years is how little programming languages have changed.
Then and now, C and C++ dominate programming at deep, or highly-optimised levels.

One level up, C-derived languages - objective C and ones resembling C in syntax, like Java and Microsoft's C# - are in fashion for running most applications.
Then at the top, there is a big brace of scripting languages, like Perl, Python (named after Monty Python), and PHP, which is often used as glue for sticking together programmes to build a complete system.
Scripting languages live in a rich environment, with large numbers of links to other programmes, says Daniel Kroening, professor of computer science at the University of Oxford.


A panel of independent experts has decided that a clot-busting drug often used to treat strokes is "safe and effective".
The UK medicines watchdog wanted after concerns were raised about its safety.
The panel concluded that the best time to use the drug is up to four and a half hours after the start of symptoms.
But some other doctors are still not convinced by the evidence.
Most strokes are caused by a clot blocking the flow of blood to the brain.
Many patients are given the drug alteplase to break down and disperse the clot - a treatment known as thrombolysis.

Benefits outweigh risks

The independent expert panel, chaired by Prof Sir Ian Weller, said it had looked at all available data on alteplase and decided that the earlier the drug was given to patients, the greater the chance of a good outcome.
Used up to four and a half hours after the onset of symptoms, the benefits of the drug were found to outweigh the risks.
But it added that the benefits of using alteplase to treat strokes were "highly time-dependent" and, in a small number of people, there was a risk of haemorrhage.
Prof Weller explained: "The evidence shows that for every 100 patients treated with alteplase, whilst there is an early risk of a fatal bleed in two patients, after three to six months, around 10 more in every 100 are disability-free when treated within three hours."
Five more patients in every 100 are left with no disabilities when treated between three and four-and-a-half hours after a stroke, he said.
However, there are still medical experts who have concerns.


"Write Reviews Get Paid", screams the advert.
This might sound a theatre critic's dream, but Craigslist's "Get $5 for Yelp review" leaves less room for such notions.
It's the seamy side of an online reviews industry which has enticed clickfarms in Bangladesh, lawyers in London, and New York's Attorney General.
And now, the UK's Competitions and Market Authority (CMA) as well, which is opening an investigation using its consumer enforcement powers, and pondering further action.
The CMA is also planning an international project on online reviews and endorsements, to coincide with Britain's year-long presidency of the International Consumer Protection and Enforcement Network, which starts 1st July.
It's big business, these new crowdsourced yellow pages of the internet. A hearty 62% of British consumers say they are likely to be affected by positive online reviews - with negative ones, that soars to 89%.


A 113-million-year-old fossil from Brazil is the first four-legged snake that scientists have ever seen.
Several other fossil snakes have have been found with hind limbs, but the new find is estimated to be a direct ancestor of modern snakes.
Its delicate arms and legs were not used for walking, but probably helped the creature to grab its prey.
The fossil shows adaptations for burrowing, not swimming, strengthening the idea that snakes evolved on land.
That debate is a long-running one among palaeontologists, and researchers say wiggle-room is running out for the idea that snakes developed from marine reptiles.
"This is the most primitive fossil snake known, and it's pretty clearly not aquatic," said Dr Nick Longrich from the University of Bath, one of the study's authors.
Speaking to Science in Action on the BBC World Service, Dr Longrich explained that the creature's tail wasn't paddle-shaped for swimming and it had no sign of fins; meanwhile its long trunk and short snout were typical of a burrower.

"It's pretty straight-up adapted for burrowing," he said.
When Dr Longrich first saw photos of the 19.5cm fossil, now christened, he was "really blown away" because he was expecting an ambiguous, in-between species.
Instead, he saw "a lot of very advanced snake features" including its hooked teeth, flexible jaw and spine - and even snake-like scales.
"And there's the gut contents - it's swallowed another vertebrate. It was preying on other animals, which is a snake feature.
"It was pretty unambiguously a snake. It's just got little arms and little legs."


Deadly embrace?

At 4mm and 7mm long respectively, those arms and legs are little indeed. But Dr Longrich was surprised to discover that they were far from being "vestigial" evolutionary leftovers, dangling uselessly.
"They're actually very highly specialised; they have very long, skinny fingers and toes, with little claws on the end. What we think [these animals] are doing is they've stopped using them for walking and they're using them for grasping their prey."